Cargando…
晚期非小细胞肺癌免疫治疗超进展的研究进展
Hyperprogressive disease (HPD) is a novel pattern of progression caused by immune checkpoint inhibitors (ICIs). It is characterized by a dramatic tumor surge and is associated with poor clinical outcomes. Up to now, the definition of HPD is still controversial across various studies. Although it has...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105608/ https://www.ncbi.nlm.nih.gov/pubmed/33910275 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.08 |